Oorsprong van het eerstegraads netwerk van Laura Kelly
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Laura Kelly via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Glycomed, Inc.
Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Glycomed, Inc. discovers and developes pharmaceuticals based on complex carbohydrates. The company's drug discovery strategy utilizes medicinal chemistry to identify biologically active small molecules for therapeutic use. The company was founded by Brian G. Atwood in 1987 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
REPLIGEN CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Comptroller/Controller/Auditor Founder Director of Finance/CFO | |
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Sensant Corp.
Sensant Corp. Medical/Nursing ServicesHealth Services Sensant Corp. provides medical imaging systems. It uses silicon ultrasound micro electro-mechanical systems or MEMS technology to provide a platform for medical imaging systems. The company was founded by Igal Ladabaum, Greg Johnstone, and Kirti Patel in 1998 and is headquartered in San Leandro, CA. | Medical/Nursing Services | Director/Board Member | |
SonarMed, Inc.
SonarMed, Inc. Electronic Equipment/InstrumentsElectronic Technology SonarMed, Inc. develops medical devices. It offers AirWave, a non invasive, adjunctive device that provides direct, precise, real time monitoring of endotracheal tube position and function, which may aid in detecting potentially dangerous or fatal endotracheal tube conditions. The firm’s product may help reduce endotracheal tube related risks and complications, thereby improving patient safety and quality of care as well as reducing cost of care. It operates through its offices located in Bryan and Carmel. The company was founded by Jeffrey P. Mansfield, Eduardo J. Juan and George R. Wodicka in 2005 and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Chief Executive Officer | |
The Bear Stearns Cos. LLC
The Bear Stearns Cos. LLC Investment Banks/BrokersFinance Part of JPMorgan Chase & Co., The Bear Stearns Cos. LLC provides investment banking and securities dealing services. The company is based in New York, NY. | Investment Banks/Brokers | President | |
PROBILITY MEDIA CORPORATION | Miscellaneous Commercial Services | Founder | |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Lung Therapeutics, Inc.
Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Founder | |
Attenuon, LLC | Chief Tech/Sci/R&D Officer | ||
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin | |
Stanford University | College/University | Graduate Degree Doctorate Degree | |
Glyko, Inc.
Glyko, Inc. Medical SpecialtiesHealth Technology Part of BioMarin Pharmaceutical, Inc., Glyko, Inc. discovers, develops, and commercializes carbohydrate enzyme therapeutics. The company is based in Novato, CA. Glyko was acquired by BioMarin Pharmaceutical, Inc. on October 08, 1998 for $14.50 million. | Medical Specialties | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
University of Cambridge | College/University | Masters Business Admin | |
Tempus, Inc.
Tempus, Inc. Beverages: Non-AlcoholicConsumer Non-Durables Part of FormCap Corp., Tempus, Inc. is a company that produces bottled beverages. The company is based in Sarasota, FL. The company was founded by Andrew P. Mazar. The CEO is Mauricio Naranjo Gonzalez. Tempus was acquired by FormCap Corp. on May 12, 2000. | Beverages: Non-Alcoholic | Founder | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Medical Distributors | Director of Finance/CFO | |
US Military Academy | College/University | Undergraduate Degree | |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
London School of Economics & Political Science | College/University | Graduate Degree | |
National Heart, Lung & Blood Institute | General Government | Corporate Officer/Principal | |
Memorex Corp.
Memorex Corp. Information Technology ServicesTechnology Services Memorex Corp. provides information technology solutions. The private company is based in Norfolk, VA. | Information Technology Services | Corporate Officer/Principal | |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director of Finance/CFO Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
University of Illinois College of Medicine | College/University | Doctorate Degree | |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Jade Therapeutics, Inc.
Jade Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Jade Therapeutics, Inc. develops pharmaceutical products. The company is based in Salt Lake City, UT. The company was founded by Barbara Wirostko. Jade Therapeutics was acquired by Kiora Pharmaceuticals, Inc. on March 07, 2016 for $5.10 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Kellogg School of Management | College/University | Masters Business Admin | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Innovation Development Institute, Inc.
Innovation Development Institute, Inc. Electronic Equipment/InstrumentsElectronic Technology Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL. | Electronic Equipment/Instruments | Director/Board Member | |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Founder | |
Faculté de Médecine Paris | College/University | Doctorate Degree | |
Wilson Therapeutics, Inc. | Director/Board Member Founder | ||
Chemistry of Life Processes Institute | College/University | Director/Board Member Corporate Officer/Principal | |
Tactic Pharma LLC
Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Tactic Pharma LLC is an American company that develops pre-clinical and clinical stage compounds. The private company was founded by Andrew P. Mazar and Chandler Drew Robinson. Chandler Drew Robinson has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
Avidtox, Inc. | Founder | ||
Valence Therapeutics, Inc. | Founder | ||
Thiogenesis Therapeutics, Inc.
Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thiogenesis Therapeutics, Inc. engages in the development of novel compounds that are based on thiols, thiol derivatives or S-H groups. The company was founded by Patrice P. Rioux and Vincent P. Stanton and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Founder | |
Pitié-Salpêtrière | College/University | Undergraduate Degree | |
THIOGENESIS THERAPEUTICS, CORP. | Financial Conglomerates | Director/Board Member Chairman Founder |
Statistieken
Internationaal
Verenigde Staten | 45 |
Verenigd Koninkrijk | 3 |
Frankrijk | 3 |
Zweden | 2 |
Canada | 2 |
Sectoraal
Health Technology | 20 |
Consumer Services | 12 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 3 |
Operationeel
Director/Board Member | 35 |
Founder | 22 |
Corporate Officer/Principal | 16 |
Chief Executive Officer | 15 |
Chief Tech/Sci/R&D Officer | 13 |
Sterkste connecties
Insiders | |
---|---|
Arthur Klausner | 16 |
Raymond Anderson | 14 |
Andrew Mazar | 14 |
Michael Brown | 12 |
Christopher Starr | 12 |
Patrice Rioux | 12 |
Kim Tsuchimoto | 11 |
Chandler Robinson | 11 |
Andrew Cittadine | 7 |
Octávio Costa | 3 |
- Beurs
- Insiders
- Laura Kelly
- Bedrijfsconnecties